Skip to content
10-K

Annual Report

NewGen BioPharma Corp.

0001640334-16-000631

← back to feed
Filed
Jan 28, 2016 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2015 · Jan 25, 2016 11.9M sh
Total Liabilities FY 2015 · Oct 31, 2014 $49.92K
Sga Expense FY 2015 · Oct 31, 2014 $4.81K
Net Income FY 2015 · Oct 31, 2014 −$43.03K
Operating Income FY 2015 · Oct 31, 2014 −$43.03K
Stockholders Equity FY 2015 · Oct 31, 2013 −$25.26K